Clinical Trials Update: March 7, 2008
Multiple Sclerosis
Moyamoya Syndrome
Pancreatic Cancer
|
E-mail this article
Subscribe to news
Printer friendly version
|
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Multiple Sclerosis
If you are aged 18 to 55, have multiple sclerosis with at least one relapse during the past year, are able to walk without aid or rest more than 100 meters, and have failed treatment with a beta-interferon, you may qualify for this study.
The research site is in Lenexa, Kansas.
More information
Please see http://www.centerwatch.com/patient/studies/cat102.html 
.
-----
Moyamoya Syndrome
If you are 18 or older and capable of informed consent, you may qualify for this study. Both asymptomatic and symptomatic patients with moyamoya will be included.
The research site is in St. Louis, Mo.
More information
Please see http://www.centerwatch.com/patient/studies/cat652.html .
-----
Pancreatic Cancer
If you are 18 or older; have unresectable, locally advanced adenocarcinoma of the pancreas proven by biopsy or cytology; have not been treated for pancreatic cancer; and have a life expectancy greater than three months, you may qualify for this study.
The research site is in Greenville, N.C.
More information
Please see http://www.centerwatch.com/patient/studies/cat35.html .
-----
Copyright 2008 Thomson CenterWatch . All rights reserved.
Copyright © 2008 ScoutNews, LLC. All rights reserved. 
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder.gov does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder.gov health library.